GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (MIL:1AFX) » Definitions » Retained Earnings

Carl Zeiss Meditec AG (MIL:1AFX) Retained Earnings : €1,392 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Carl Zeiss Meditec AG Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Carl Zeiss Meditec AG's retained earnings for the quarter that ended in Mar. 2024 was €1,392 Mil.

Carl Zeiss Meditec AG's quarterly retained earnings declined from Sep. 2023 (€1,406 Mil) to Dec. 2023 (€0 Mil) but then increased from Dec. 2023 (€0 Mil) to Mar. 2024 (€1,392 Mil).

Carl Zeiss Meditec AG's annual retained earnings increased from Sep. 2021 (€1,000 Mil) to Sep. 2022 (€1,214 Mil) and increased from Sep. 2022 (€1,214 Mil) to Sep. 2023 (€1,406 Mil).


Carl Zeiss Meditec AG Retained Earnings Historical Data

The historical data trend for Carl Zeiss Meditec AG's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Retained Earnings Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 744.67 808.92 1,000.48 1,213.89 1,405.90

Carl Zeiss Meditec AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,228.55 - 1,405.90 - 1,391.57

Carl Zeiss Meditec AG Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Carl Zeiss Meditec AG  (MIL:1AFX) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Carl Zeiss Meditec AG (MIL:1AFX) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (MIL:1AFX) Headlines

No Headlines